Page last updated: 2024-12-07

tricine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tricine, or N-tris(hydroxymethyl)methylglycine, is an amino acid analog that has been widely used as a buffering agent in biological research. It is a non-toxic, non-metabolizable, and readily available compound. Tricine is often used in electrophoresis, particularly for separating proteins of different sizes and for creating gels with higher resolution. It is also employed in enzyme kinetics and cell culture studies due to its ability to maintain a stable pH environment. The synthesis of tricine involves a reaction between glycine and formaldehyde in the presence of a catalyst. Its effectiveness as a buffer stems from its pKa value of 8.15, which falls within the physiological pH range. Tricine is particularly important in the study of protein structure and function because it can help to maintain the integrity of proteins during electrophoresis and other biochemical assays. Its use allows researchers to obtain accurate and reproducible results. The research interest in tricine arises from its versatile applications in biological research. Its buffering capacity, non-toxicity, and stability make it a valuable tool for various techniques, including electrophoresis, enzyme kinetics, and cell culture.'

N-tris(hydroxymethyl)methylglycine : A Good's buffer substance, pKa = 8.15 at 20 degreeC. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID79784
CHEBI ID39063
MeSH IDM0262925

Synonyms (47)

Synonym
glycine, n-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]-
glycine, n-(2-hydroxy-1,1-bis(hydroxymethyl)ethyl)-
ai3-62523
w12lh4v8v3 ,
nsc 369995
unii-w12lh4v8v3
einecs 227-193-6
nsc369995
nsc-369995
5704-04-1
c6h13no5
tricine, >=99% (titration)
tricine, bioperformance certified, cell culture tested, >=99% (titration)
tricine, bioxtra, ph 4.0-6.0 (1 m in h2o), >=99% (titration)
n-tris(hydroxymethyl)methylglycine
n-(tri(hydroxymethyl)methyl)glycine
CHEBI:39063
tricine ,
n-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine
FT-0651933
T0682
n-[tris(hydroxymethyl)methyl]glycine
2-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]acetic acid
A831289
AKOS015856413
n-(2-hydroxy-1,1-bis(hydroxymethyl)ethyl)glycine
tricine [mi]
n-(tris(hydroxymethyl)methyl)glycine
DTXSID1063982
W-105489
2-((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)acetic acid
([2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino)acetic acid #
mfcd00004277
2-{[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino}acetic acid
tricine, >=98%
tricine, anhydrous, free-flowing, redi-dri(tm), >=99%
tricine, vetec(tm) reagent grade, >=99%
2-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-ylamino)acetic acid
Q409516
F20298
DS-13693
n-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]glycine
VLS ,
CS-0015170
2-((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)aceticacid
2-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino}acetic acid
HY-D0860

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Treatment with Tricine buffer or EIPA (a NHE inhibitor) reduced the H(+) gradient and ammonia excretion of larvae."( Proton-facilitated ammonia excretion by ionocytes of medaka (Oryzias latipes) acclimated to seawater.
Horng, JL; Lin, LY; Liu, ST; Tsung, L, 2013
)
0.73

Dosage Studied

ExcerptRelevanceReference
" A Zn(2+) chelating agent, tricine, potentiated GABA currents for the alphabeta constructs and vertically displaced GABA dose-response curves, suggesting that these receptors are subject to some inhibition by basal Zn(2+)."( Redox modulation of GABAA receptors obscured by Zn2+ complexation.
Smart, TG; Wilkins, ME, 2002
)
0.61
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tricine
tricine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (104)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (7.69)18.7374
1990's19 (18.27)18.2507
2000's39 (37.50)29.6817
2010's33 (31.73)24.3611
2020's5 (4.81)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.55 (24.57)
Research Supply Index4.78 (2.92)
Research Growth Index4.85 (4.65)
Search Engine Demand Index79.70 (26.88)
Search Engine Supply Index2.02 (0.95)

This Compound (50.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.85%)5.53%
Reviews4 (3.42%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other112 (95.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]